ISTH 2022 Congress

Coagulation and Natural Anticoagulants » Protein C Pathway

Theme Navigation

ISTH 2022 Congress
- Coagulation and Natural Anticoagulants
  - Protein C Pathway

Abstract Number: OC 65.3

A Phase 2 Trial Evaluating the Safety and Antithrombotic Efficacy of AB002, a First-in-class Protein C Activator in End-stage Renal Disease Patients on Heparin-free Hemodialysis

N. Verbout¹, C. Lorentz¹, B. Markway¹, M. Wallisch¹, J. Shatzel², E. Tucker¹

Abstract Number: PB1030

Erythrocytes impair the anticoagulant function of the protein C system in whole blood thrombin generation.

J. Wan¹, J. Konings², B. de Laat³, D. Huskens⁴, M. Roest⁵

Abstract Number: PB1029

Identification and functional characterisation of alternatively spliced novel isoforms of human protein C (PROC) gene

S. Abul Kalam¹, F. Naaz²

Abstract Number: OC 67.2

Personalized Assessment of the Protein C Pathway Using Endothelial Colony Forming Cells

N. Schwarz¹, J. Müller², H. Yadegari³, J. Oldenburg⁴, B. Pötzsch³, H. Rühl³

Abstract Number: PB1031

Real-world treatment of severe congenital protein C deficiency with protein C concentrate including prophylaxis: A physician survey in Europe and the US

M. Wang¹, C. Siffel², P. Turecek³, H. Gazda², S. Fung⁴, E. Swallow⁵, A. Greatsinger⁵, E. Billmyer⁵, H. Hertfelder⁶

« View all themes from the ISTH 2022 Congress